What Theyre FDA-Approved For Currently, GLP-1 medications are approved for: Type 2 diabetes Obesity and weight management Reducing cardiovascular risk in people with heart or kidney disease MASH (metabolic-associated steatohepatitis) , formerly called NASH, a type of fatty liver disease Microdosing: What It Means Microdosing usually refers to staying at a very low dosesay, 0.25 mg of semaglutidelong-term, rather than gradually increasing to the therapeutic dose
Good Analysis as always Connor and i still feel scientific challenges would increase for GLP-1s as long term data emerge and not all data is all clear
Until recently, there was a tirzepatide shortage because of the high demand
Monitoring & Adjustments Regular check-ins help manage side effectscommon ones include nausea, constipation, and headaches
Clinical Perspective: Constipation should not be an acceptable tax for taking metabolic medications
research-subject metallothionein MT-I and MT-II processed genes